- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2008
- Public Summary Document (PSD) March 2008 PBAC Meeting - PDF
Bevacizumab – March 2008
Bevacizumab, solution for I.V. infusion, 100 mg in 4 mL, 400 mg in 16 mL, Avastin, March 2008
Last updated
18 July 2008